Italy· 026738017
SELEPARINA*6 siringhe SC 2.850 UI 0,3 ml
A medicinal product containing nadroparina, registered in Italy by VIATRIS ITALIA Srl, on the national reimbursement list.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Active substance
- Nadroparina
- Manufacturer
- VIATRIS ITALIA Srl
- Country
- Italy (IT)
- ATC code
- —
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic026738017SELEPARINA*6 siringhe SC 2.850 UI 0,3 mlEUR 18.94
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nadroparina in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsFraxiparine 2.850 IE/ 0,3 ml oplossing voor injectieMedcor Pharmaceuticals B.V.
- SwitzerlandFraxiforte 0.6 ml
- FranceFRAXIPARINE 1 900 U.I. Axa/0,2 ml, solution injectable (S.C.) en seringue pré-remplieVIATRIS SANTE
- SpainFRAXIPARINA 0,3 ml SOLUCION INYECTABLEAspen Pharma Trading Limited
- PolandFraxiparineViatris Healthcare Sp. z o.o.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d2d39d64-48fa-4eef-b4d5-6bfaa76bd67f GET /v1/drugs/d2d39d64-48fa-4eef-b4d5-6bfaa76bd67f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 18.94,
"source": "aifa",
"currency": "EUR",
"strength": "NADROPARINA 2.850UI aXa/0,3ML 6 UNITA' USO PARENTERALE",
"substance": "Nadroparina",
"equivalence_group": "D3A",
"transparency_flag": null
}See everything about nadroparina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.